Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger D Weiss

Showing results (261-270 of 271) with videos related to

Pageof 28
Sort By:
JAMA|May 4, 2006
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trialRaymond F Anton, Stephanie S O'Malley, Domenic A Ciraulo, et al.
Archives of General Psychiatry|November 9, 2011
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trialRoger D Weiss, Jennifer Sharpe Potter, David A Fiellin, et al.
Addiction (Abingdon, England)|March 16, 2022
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus studyNiranjan S Karnik, John Marsden, Connor McCluskey, et al.
Iscience|July 18, 2024
Toward AI-driven neuroepigenetic imaging biomarker for alcohol use disorder: A proof-of-concept studyTewodros Mulugeta Dagnew, Chieh-En J Tseng, Chi-Hyeon Yoo, et al.
Pain|June 25, 2013
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsShannon M Smith, Richard C Dart, Nathaniel P Katz, et al.
Drug and Alcohol Dependence|May 4, 2020
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agendaMallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
Pain|July 10, 2012
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendationsDennis C Turk, Alec B O'Connor, Robert H Dworkin, et al.
Drug and Alcohol Dependence|April 16, 2024
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trialLaShawn Glasgow, Christian Douglas, Joel G Sprunger, et al.
The American Journal of Psychiatry|June 16, 2007
Treatment of patients with substance use disorders, second edition. American Psychiatric AssociationHerbert D Kleber, Roger D Weiss, Raymond F Anton, et al.
Pageof 28

Showing results (261-270 of 271) with videos related to

Sort By:
Pageof 28
JAMA|May 4, 2006
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trialRaymond F Anton, Stephanie S O'Malley, Domenic A Ciraulo, et al.
Archives of General Psychiatry|November 9, 2011
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trialRoger D Weiss, Jennifer Sharpe Potter, David A Fiellin, et al.
Addiction (Abingdon, England)|March 16, 2022
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus studyNiranjan S Karnik, John Marsden, Connor McCluskey, et al.
Iscience|July 18, 2024
Toward AI-driven neuroepigenetic imaging biomarker for alcohol use disorder: A proof-of-concept studyTewodros Mulugeta Dagnew, Chieh-En J Tseng, Chi-Hyeon Yoo, et al.
Pain|June 25, 2013
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsShannon M Smith, Richard C Dart, Nathaniel P Katz, et al.
Drug and Alcohol Dependence|May 4, 2020
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agendaMallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
Pain|July 10, 2012
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendationsDennis C Turk, Alec B O'Connor, Robert H Dworkin, et al.
Drug and Alcohol Dependence|April 16, 2024
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trialLaShawn Glasgow, Christian Douglas, Joel G Sprunger, et al.
The American Journal of Psychiatry|June 16, 2007
Treatment of patients with substance use disorders, second edition. American Psychiatric AssociationHerbert D Kleber, Roger D Weiss, Raymond F Anton, et al.
Pageof 28